reference/25804085

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25804085

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	1559-131X 1357-0560
issueIdentifier	4
pageRange	33-
publicationName	Medical oncology (Northwood, London, England)
startingPage	33
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1c0aa062611518a12552a116a65f748d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_74cfa2d9660d0dfd65884b847f6f84f4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d1aff7a0a2f85bbb978e67852b8fee94 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_612c17ac5f218cdcaee6395bec3e5dbf http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_588a941f63549c29a0f481fa17609ba0 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f8b6f2126b697989005c466954aad68b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6033ac2fd1d9c303fb47b745ba4793c2
bibliographicCitation	Li J, Huang Y, Zhang Y, Wen J, Chen Y, Wang L, Jiang P, Hu J. Identification BCL6 and miR-30 family associating with Ibrutinib resistance in activated B-cell-like diffuse large B-cell lymphoma. Medical Oncology. 2021 Feb 25;38(4):33. doi: 10.1007/s12032-021-01470-5.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d568396b7407bb34cdd9f981a4f77619 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4fe2b61058e8e5dc17ce1a50643b3886 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9137fe389d3788dfc8786b5f58f9a09a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e798d49f7bc4bf4ef099f60981b1993 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1606dcaae93171318391ae5e27bc45d2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a42adf4a47bcc0a877cf7a24742e3200 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_69330bddc880973b1409249c6911b122 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4438-2544
date	2021-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/33629212 https://pubmed.ncbi.nlm.nih.gov/PMC7904539 https://doi.org/10.1007/s12032-021-01470-5
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8582 https://portal.issn.org/resource/ISSN/1357-0560 https://portal.issn.org/resource/ISSN/1559-131X
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Identification BCL6 and miR-30 family associating with Ibrutinib resistance in activated B-cell-like diffuse large B-cell lymphoma
discusses	http://id.nlm.nih.gov/mesh/M0407989 http://id.nlm.nih.gov/mesh/M0576729 http://id.nlm.nih.gov/mesh/M000636305 http://id.nlm.nih.gov/mesh/M0222844 http://id.nlm.nih.gov/mesh/M0223576 http://id.nlm.nih.gov/mesh/M0447306 http://id.nlm.nih.gov/mesh/M0000347 http://id.nlm.nih.gov/mesh/M0011238 http://id.nlm.nih.gov/mesh/M0542340 http://id.nlm.nih.gov/mesh/M0016885
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9859 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24821094 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1a39815205e3163e4bf06d83b612087f http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d42082ec92265ade434121049e6fb546 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_07f1a4059026e0b860f67d47d4520817 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_693a40f9999e81cd8630fc8267346349 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f4293d1b2f6ddd1d063a3ad921c9f44c http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bdee05d2bdf8d586a226582f9620b8dc http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_93b3e3ea2095c29609318f22739564ba http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_14c4bc691cbdf05c0a713be04d216c32 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_564f64348efdade903a3b83a985759d0 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_87f11a2c599b2f3cfbbc816705b2fbee

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID604

Total number of triples: 59.